Form 8-K - Current report:
SEC Accession No. 0001437749-24-037557
Filing Date
2024-12-16
Accepted
2024-12-16 13:53:10
Documents
15
Period of Report
2024-12-10
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cyan20241214_8k.htm   iXBRL 8-K 32169
2 EXHIBIT 16.1 ex_757546.htm EX-16.1 3072
  Complete submission text file 0001437749-24-037557.txt   161245

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cyan-20241210.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cyan-20241210_def.xml EX-101.DEF 10737
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cyan-20241210_lab.xml EX-101.LAB 14385
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cyan-20241210_pre.xml EX-101.PRE 10787
17 EXTRACTED XBRL INSTANCE DOCUMENT cyan20241214_8k_htm.xml XML 2672
Mailing Address 73-4460 QUEEN KAAHUMANU HWY SUITE 102 KAILUA-KONA HI 96740
Business Address 73-4460 QUEEN KAAHUMANU HWY SUITE 102 KAILUA KONA HI 96740 8083261353
CYANOTECH CORP (Filer) CIK: 0000768408 (see all company filings)

EIN.: 911206026 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-14602 | Film No.: 241551233
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)